Bayer Says One A Day Selenium Prostate Cancer Claims Are In Fair Play
This article was originally published in The Tan Sheet
Executive Summary
Bayer asserts the prostate cancer risk reduction claims for its One A Day Men's multivitamin supplements are backed by an FDA-approved qualified health claim for selenium
You may also be interested in...
FDA Looms Large As Bayer Surrenders One A Day Selenium Prostate Claims
Bayer seems to be heeding FDA's message that the administration will not tolerate playing fast and loose with health claims
FDA Cheerios Warning Signals Tougher Stance On Health Claims Enforcement
FDA's warning letter to General Mills concerning cardiovascular health claims linked to Cheerios reflects a newly empowered agency and foreshadows aggressive regulatory activity to come, experts say
Bayer Loses Oversight Of Yaz DTC Ads Under Agreement With States Attorneys General
FDA has oversight over DTC advertising for Bayer’s Yaz contraceptive after the company violated an earlier agreement with state attorneys general.